title: Response to letter to the editor "Zink TK. Vaccine 2007;25(15):2766-7".
authors.forename: Geoffrey J
authors.initials: GJ
authors.lastname: Gorse
authors.forename: Wendy
authors.initials: W
authors.lastname: Keitel
authors.forename: Harry
authors.initials: H
authors.lastname: Keyserling
authors.forename: David N
authors.initials: DN
authors.lastname: Taylor
authors.forename: Michael
authors.initials: M
authors.lastname: Lock
authors.forename: Katia
authors.initials: K
authors.lastname: Alves
authors.forename: Julie
authors.initials: J
authors.lastname: Kenner
authors.forename: Lynne
authors.initials: L
authors.lastname: Deans
authors.forename: Marc
authors.initials: M
authors.lastname: Gurwith
mesh_terms: D022122:Anthrax Vaccines / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012449:Safety; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000494:pharmacology
chemical_list: D022122:Anthrax Vaccines; C493276:Biothrax; D014614:Vaccines, Synthetic